Tresiba

Active Ingredient(s): Insulin Degludec
FDA Approved: * September 25, 2015
Pharm Company: * NOVO NORDISK INC
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Tresiba Overview

Insulin degludec (INN/USAN) is an ultralong-acting basal insulin analogue that was developed by Novo Nordisk under the brand name Tresiba.[1] It is administered via subcutaneous injection once daily to help control the blood sugar level of those with diabetes. It has a duration of action that lasts up to 42 hours (compared to 18 to 26 hours provided by other marketed long-acting insulins such as insulin glargine and insulin detemir), making it a once-daily basal insulin,&...

Read more Tresiba Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Insulin_degludec

Recent Tresiba Forums: RSS Feed

What happens when your blood sugars go up? After double dose

double dosed on Tresiba 9 hours ago. after taking my BS started to RISE and in a hr & half it was 150 points higher, then it began to go down to 120 ..now it is rising again. HELP It is now night and I don't want a high like this morning to damage my kidneys which are low function. ## Why did you take a double dose of it? And what did you eat? Even though you take this medication, you can't expect it to do everything, you have to help it work by eating a low fat, low sugar diet, and getting lots of proper exercise to help control your blood sugar, according to the NIH. As to the Tresiba, it doesn't start working until a few hours after taking it, so you will not see an immediate lowering, according to the manufacturer.

Updated

Possible Dosages for this and Related Drugs:

Insulin Degludec
  • Injection: 100units/ml, 200units/ml
  • Solution: 300 Units/3ml (100 Units/ml), 600 Units/3ml (200 Units/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Tresiba: (4 results)

Sorted by National Drug Code
  • 0169-2550 Tresiba 200 U/Ml Subcutaneous Injection, Solution by Novo Nordisk
  • 0169-2660 Tresiba 100 U/Ml Subcutaneous Injection, Solution by Novo Nordisk
  • 0169-2662 Tresiba 100 U/Ml Subcutaneous Injection, Solution by Novo Nordisk
  • 50090-3491 Tresiba 200 U/Ml Subcutaneous Injection, Solution by A-s Medication Solutions

Other drugs which contain Insulin Degludec or a similar ingredient: (5 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 July 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA